Haghnazari Lida, Sabzi Ramin
Department of Clinical Biochemistry, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
J Med Life. 2021 Jan-Mar;14(1):37-44. doi: 10.25122/jml-2019-0150.
Diabetes mellitus (DM) is a metabolic disorder that results from insufficient secretion or insulin resistance, or both. Insulin secretion deficiency leads to chronic hyperglycemia along with impaired metabolism of proteins, lipids, and carbohydrates. This study aimed to investigate the TP53 gene SNP (single nucleotide polymorphism) rs1042522 genotype and the interleukin-6 (IL-6) gene SNP rs1800795 genotype in DM and control groups. This study was performed on 70 patients with type 1 DM, 100 patients with type 2 DM without related complications, 66 control subjects for type 1 DM, and 95 control subjects for type 2 DM. The control groups were matched regarding age and gender and did not have a familial relationship with the patient groups. All the subjects were residents of Kermanshah, located in the western part of Iran. Polymorphisms of TP53 and IL-6 genes were determined by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Lipid profile, fasting blood glucose, and HbA1c were measured using the ELISA and immunoturbidometric methods. The frequency of genotypes (CC, CG, GG) of the TP53 gene codon 72 in type 1 DM and its control group were significantly different (P= 0.013). Likewise, the frequency of genotypes (CC, CG, GG) of the TP53 gene codon 72 was significantly different between type 2 DM and control groups (P <0.001). The frequency of genotypes (GG, GC, CC) of G174C polymorphisms in the IL-6 gene was different between type 1 DM and control group as well as between type 2 DM and its control group, but it was not statistically significant. SNP rs1042522 genotypes in the dominant form (CG + GG vs. CC) (OR= 3.880; P < 0.001) and alleles G vs. C alleles (OR= 0.384; P < 0.001) increased the risk of type 2 DM significantly. There was no significant difference between type 1 and type 2 DM groups and respected control groups regarding the frequency of the IL-6 gene SNP rs1800795 alleles. The G allele of SNP rs1042522 encoding the TP53 gene increases the risk of developing DM in the population of the Kermanshah province, Iran.
糖尿病(DM)是一种由胰岛素分泌不足或胰岛素抵抗或两者共同引起的代谢紊乱疾病。胰岛素分泌不足会导致慢性高血糖,并伴有蛋白质、脂质和碳水化合物代谢受损。本研究旨在调查1型糖尿病组、2型糖尿病组及对照组中TP53基因单核苷酸多态性(SNP)rs1042522基因型和白细胞介素-6(IL-6)基因SNP rs1800795基因型。本研究纳入了70例1型糖尿病患者、100例无相关并发症的2型糖尿病患者、66例1型糖尿病对照组受试者和95例2型糖尿病对照组受试者。对照组在年龄和性别上进行了匹配,且与患者组无家族关系。所有受试者均为伊朗西部克尔曼沙赫的居民。采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法测定TP53和IL-6基因的多态性。使用酶联免疫吸附测定(ELISA)和免疫比浊法测量血脂、空腹血糖和糖化血红蛋白(HbA1c)。1型糖尿病组及其对照组中TP53基因密码子72的基因型(CC、CG、GG)频率有显著差异(P = 0.013)。同样,2型糖尿病组与对照组之间TP53基因密码子72的基因型(CC、CG、GG)频率也有显著差异(P <0.001)。IL-6基因G174C多态性的基因型(GG、GC、CC)频率在1型糖尿病组与对照组以及2型糖尿病组与对照组之间存在差异,但无统计学意义。SNP rs1042522基因型显性形式(CG + GG vs. CC)(比值比[OR]= 3.880;P <0.001)以及等位基因G与C等位基因(OR= 0.384;P <0.001)显著增加了2型糖尿病的发病风险。1型糖尿病组与2型糖尿病组及其相应对照组在IL-6基因SNP rs1800795等位基因频率方面无显著差异。编码TP53基因的SNP rs1042522的G等位基因增加了伊朗克尔曼沙赫省人群患糖尿病的风险。